‍🏥 Laborie inks $465M deal to buy post-childbirth device from Organon‍

Organon sells its postpartum hemorrhage device to refocus on core women’s health priorities.

"Childbirth is one of the most personal and profound moments in a woman’s life, and every mother deserves to feel supported throughout it."

— Chris Smith, President & CEO of Laborie

🔗 Read More

‍

📡 Muun Health Raises €545K Pre-Seed for Hormone-Tracking Wearable‍

Estonia’s Muun develops a real-time biosensor for women’s hormone monitoring.

🔗 Read More

‍

🧬 Essity Acquires Edgewell’s Feminine-Care Portfolio‍

Stayfree, Carefree, and Playtex join Essity’s global hygiene and health portfolio.

🔗 Read More

‍

💡 Midi Health & Herself Health Partner for Midlife Care‍

The two platforms team up to deliver a continuum of care for women in midlife and beyond.

🔗 Read More

‍

⚖️ FDA Removes Misleading Warnings from HRT Labels

A historic policy shift modernises hormone-replacement guidance for menopausal women.

“Today, we are standing up for every woman who has symptoms of menopause and is looking to know her options and receive potentially life-changing treatment,”

— Robert F. Kennedy, Health and Human Services Secretary, FDA

🔗 Read More

‍

🌍 Melinda Gates Announces New Women’s Health Focus‍

Her foundation launches a new global strategy to accelerate women’s health equity.‍

"There is no path to that future if women are having to fight unwinnable battles just to receive basic healthcare”

— Melinda French Gates, Co-Founder & Co-Chair, Gates Foundation

🔗 Read More

‍

Another big week! Let us know what you're working on, or who we should feature next.  

‍Email us at info@womenshealthweek.com and put "Scoop Request" as the subject!